D. Shapiro and D. Schwartz, Exposure of Laboratory Workers to Francisella tularensis despite a Bioterrorism Procedure, Journal of Clinical Microbiology, vol.40, issue.6, pp.2278-8131, 2002.
DOI : 10.1128/JCM.40.6.2278-2281.2002

B. Loveless, A. Yermakova, D. Christensen, J. Kondig, H. Heine et al., Identification of ciprofloxacin resistance by SimpleProbe???, High Resolution Melt and Pyrosequencing??? nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis, Molecular and Cellular Probes, vol.24, issue.3, pp.154-60, 2010.
DOI : 10.1016/j.mcp.2010.01.003

G. Jacoby, Mechanisms of Resistance to Quinolones, Clinical Infectious Diseases, vol.41, issue.Supplement 2, p.41, 2005.
DOI : 10.1086/428052

M. Evans, D. Gregory, W. Schaffner, and Z. Mcgee, PubMed PMID: 15942878 Epub Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore), Suppl, vol.264, issue.44, pp.120-6251, 1985.

P. Larsson, P. Oyston, P. Chain, M. Chu, M. Duffield et al., The complete genome sequence of Francisella tularensis, the causative agent of tularemia, Nature Genetics, vol.18, issue.2, pp.153-162, 2005.
DOI : 10.1186/gb-2003-4-9-r54

A. Lc, Francisella tularensis et tularémie In: Bioforma, editor. Des agents trés spéciaux en bactériologie2007, pp.12-54

S. Mohamed, A. Mubarak, and L. Alfarooq, Francisella tularensis Bacteremia: A Case Report from Sudan, Case Rep Infect Dis, vol.2012, p.405737, 2012.

D. Gurycová, A. Sjostedt, and R. Titball, First isolation of Francisella tularensis subsp. tularensis in Europe Tularaemia: bioterrorism defence renews interest in Francisella tularensis, Eur J Epidemiol. Nat Rev Microbiol, vol.142, issue.812, pp.797-802967, 1998.

W. Li, D. Raoult, J. Rolain, L. Scola, B. Bachiller-luque et al., Evidence of circulation of an epidemic strain of Francisella tularensis in France by multispacer typing PubMed PMID: 21611870 Epub 2011/05/26. eng. 14. Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations Tularemia epidemic in northwestern Spain: clinical description and therapeutic response, Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis, pp.1135-81, 2001.

N. Madani, M. Maurin, B. Garin-bastuji, V. Vaillant, Y. Nakazawa et al., Unexpected increase of human and animal tularemia cases during winter France: Emergence or shortlasting episode? PubMed PMID: 20044227 Exces de cas humains et animaux de tularemie en France au cours de l'hiver : emergence ou phenomene isole ? fre. 18 Climate change effects on plague and tularemia in the United States Emerg Infect Dis, PubMed PMID: 18047395. eng. 19. Avashia SB, Petersen JM, Lindley CM, Schriefer ME, Gage KL, Cetron M, pp.279-84529, 2002.

H. Abd, T. Johansson, I. Golovliov, G. Sandstrom, and M. Forsman, Survival and Growth of Francisella tularensis in Acanthamoeba castellanii, Applied and Environmental Microbiology, vol.69, issue.1, 2003.
DOI : 10.1128/AEM.69.1.600-606.2003

I. Pelloux, J. Brion, D. Bano, J. Picard, and A. , PubMed PMID: 12514047. Pubmed Central PMCID: 152416 Human tularemia in France, Epub 2003/01/07. eng. 21. Maurin M, pp.600-606, 2006.

M. Chu, New approaches to diagnosis and therapy of tularemia, pp.1601-1607

A. Sci, U. Eriksson, L. Berglund, A. R. Tärnvik, and M. Forsman, PubMed PMID: 17468229. Epub Detection of Francisella tularensis in ulcers of patients with tularemia by PCR, J Clin Microbiol, vol.110535, issue.5, pp.378-4041045, 1997.

J. Versage, D. Severin, M. Chu, J. Petersen, T. Maier et al., Development of a multitarget realtime TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens PubMed PMID: 14662930. Pubmed Central PMCID: 309004 Identification of Francisella tularensis by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry: fast, reliable, robust, and cost-effective differentiation on species and subspecies levels, J Clin Microbiol. J Clin Microbiol, vol.4148, issue.124, pp.5492-91061, 2003.

D. Hollis and C. Thornsberry, Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth, J Antimicrob Chemother. J Clin Microbiol, 1985.

N. Mersali and D. Raoult, PubMed PMID: 4031036. Pubmed Central PMCID: 268361 Bactericidal activities of antibiotics against intracellular Francisella tularensis, Antimicrob Agents Chemother, vol.2244, issue.212, pp.212-53428, 2000.

T. Piercy, J. Steward, M. Lever, and T. Brooks, In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice, Journal of Antimicrobial Chemotherapy, vol.56, issue.6, 2005.
DOI : 10.1093/jac/dki359

K. Elkarkouri, W. Li, T. Wahab, G. Fournous, and J. Rolain, PubMed PMID: 16223941 Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm, Epub La Scola B, vol.56, issue.6, pp.1069-73, 2005.

M. Hepburn and A. Simpson, PubMed PMID: 18407970. Pubmed Central PMCID: 2336804 Tularemia: current diagnosis and treatment options, Genome Res. Epub Expert Rev Anti Infect Ther, vol.186, issue.52, pp.742-50231, 2008.

S. Ahmad, L. Hunter, A. Qin, B. Mann, M. Van-hoek et al., Azithromycin effectiveness against intracellular infections of Francisella Ciprofloxacin for treatment of tularemia in children The new fluoroquinolones: A critical review Pharmacokinetics and pharmacodynamics of antibacterial agents, BMC Microbiol. Pediatr Infect Dis J. Can J Infect Dis. Infect Dis Clin North Am. Int J Antimicrob Agents, vol.10191023, issue.534, pp.123449-53207, 1997.

M. Cabral, J. Jackson, A. Smith, C. Shikotra, N. Maxwell et al., Crystal structure of the breakage-reunion domain of DNA gyrase PubMed PMID: 9278055 Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy Quinolone resistance: much more than predicted The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice Plasmid-mediated quinolone resistance: a multifaceted threat, Nature. J Antimicrob Chemother. Front Microbiol. FEMS Microbiol Lett. Feb Clin Microbiol Rev, vol.93885922792210, issue.16645624, pp.61-70903, 1997.

E. Ferri, In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents, Res Vet Sci, vol.76, issue.3, pp.195-203, 2004.

H. Syrjala, J. Karhukorpi, R. Schildt, M. Koskela, S. Urich et al., In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis, PubMed PMID: 15046952. 45. Ikaheimo I, pp.287-90, 2000.

S. Urich and J. Petersen, In Vitro Susceptibility of Isolates of Francisella tularensis Types A and B from North America, Antimicrobial Agents and Chemotherapy, vol.52, issue.6, pp.2276-2284, 2008.
DOI : 10.1128/AAC.01584-07

A. Gonzalez, I. Garcia, J. Leblanc, S. Campbell, J. Pettipas et al., Treatment of tularemia with ciprofloxacin PubMed PMID: 10987739. 49 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing Herpes simplex virus type 2 displays atypical melting-temperature profiles at low viral titers Simultaneous pathogen detection and antibiotic resistance characterization using SNP-based multiplexed oligonucleotide ligation-PCR (MOL-PCR) Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus, Clin Infect Dis. Nineteenth Informational Supplement.M100-S19. J Clin Microbiol. Adv Exp Med Biol. Antimicrob Agents Chemother, vol.31294668037, issue.5086, pp.6232786-9455, 1993.

S. Gillespie, S. Basu, A. Dickens, O. Sullivan, D. Mchugh et al., Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates PubMed PMID: 15956099 Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey, J Antimicrob Chemother. Epub Scand J Infect Dis. J Antimicrob Chemother, vol.56163966, issue.21011, pp.344-8880, 2005.

P. Pubmed, P. Russell, S. Eley, M. Fulop, D. Bell et al., The efficacy of ciprofloxacin and doxycycline against experimental tularaemia, J Antimicrob Chemother, vol.41, pp.21856791-56, 1998.

G. Celebi, F. Baruonu, F. Ayoglu, F. Cinar, A. Karadenizli et al., Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses Ciprofloxacin for treatment of tularemia, Jpn J Infect Dis. Clin Infect Dis, vol.59, issue.33, pp.229-263, 2006.

C. Wagner, R. Sauermann, C. Joukhadar, and J. Mazza, Principles of antibiotic penetration into abscess fluid Effect of the abscess environment on the antimicrobial activity of ciprofloxacin, Pharmacology. Am J Med, vol.7887, issue.15A, pp.1-1023, 1989.

J. Oliver, E. Henningson, E. Larsson, T. Johansson, and G. Sandstrom, Francisella tularensis does not manifest virulence in viable but non-culturable state, Recent findings on the viable but nonculturable state in pathogenic bacteria, pp.415-25217, 2000.